Paibel Aguayo-Hiraldo, MD
Hematopoietic stem cell transplant for non-malignant disorders, especially HLH, Congenital Immunodeficiencies, and immune dysregulation. Immune reconstitution after hematopoietic stem cell transplant. Management and reduction of post-transplant toxicity, specifically Graft versus host disease and Transplant associated Thrombotic microangiopathy.
Education
San Juan Bautista School of Medicine, Puerto Rico
Internal Medicine-Pediatrics, Morsani College of Medicine, University of South Florida, Tampa, Florida
Baylor College of Medicine/Texas Children’s Hospital- Pediatric Hematology and Oncology
Baylor College of Medicine/Texas Children’s Hospital- Pediatric Bone Marrow Transplant-Advanced fellowship
Accomplishments
Internal Medicine, American Board of Internal Medicine
Pediatric Hematology and Oncology, American Board of Pediatrics
Pediatrics, American Board of Pediatrics
American Society for Transplant and Cellular Therapy (ASTCT, previously ASBMT)
Histiocyte Society
American Society of Hematology (ASH)
Pediatric Transplant and Cellular Therapy Consortium (PTCTC) [previously Blood and Marrow Transplant Consortium (PBMTC)]
Pediatric Acute Lung Injury and Sepsis-Hematopoietic Stem cell transplant cohort (PALISI-HSCT)
American College of Physicians (ACP)
American Association of Medical Colleges (AAMC)
4650 Sunset Blvd.
Los Angeles, CA 90027
United States
